Join us a GRx+Biosims 2021 — Progress + Process @accessiblemeds
Join us a GRx+Biosims 2021 — Progress + Process  @accessiblemeds
Uploaded September 2021 | Updated November 2026, 3 hours ago
GRx+Biosims is the premier scientific and regulatory event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals. Hear from FDA Acting Commissioner Dr. Janet Woodcock and other FDA officials including Drs. Jacqueline Corrigan-Curay, Elizabeth Miller, Sally Choe, Michael Kopcha, Donald Ashley, Gerald Dal Pan, Sarah Yim and more; share knowledge and best practices; and gain insights on navigating regulatory process approvals and the evolving policy landscape. Take advantage of the early bird special and register today!

Learn more: grxbiosims.org
Join us a GRx+Biosims 2021 — Progress + ProcessAAM Lifetime Achievement Award at Access! 2022GRx+Biosims 2022Christine Simmon: Policy and Biosimilars Sessions at the GRx+Biosims 2020 Virtual ConferencePatient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeekGeneric Drugs Are the Prescription for Savings. Dont Take Them for Granted.The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMedsMessage from CEO Dan Leonard on Access! 2021AAM All Access Promo: Mary Beth PowersGeneric Rx Drugs: Take With Confidence (Jonnie)Join Us at GRx+Biosims 2023Highlights from Craig Burton on the Newly Released 2018 Generic Drug Access & Savings Report
Association for Accessible Medicines |

Join us a GRx+Biosims 2021 — Progress + Process

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER